Cell therapies in ovarian cancer

Epithelial ovarian cancer (EOC) is the most important cause of gynecological cancer-related mortality. Despite improvements in medical therapies, particularly with the incorporation of drugs targeting homologous recombination deficiency, EOC survival rates remain low. Adoptive cell therapy (ACT) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarivalasis, Apostolos, Morotti, Matteo, Mulvey, Arthur, Imbimbo, Martina, Coukos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Immunotherapy in Gynecological Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072818/
https://www.ncbi.nlm.nih.gov/pubmed/33995591
http://dx.doi.org/10.1177/17588359211008399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072818/
https://www.ncbi.nlm.nih.gov/pubmed/33995591
http://dx.doi.org/10.1177/17588359211008399

Ejemplares similares